Following receipt of dupilumab for 24 weeks, desensitization to peanut exposure in most children/adolescents with peanut allergy was not achieved, according to study results. Image: Adobe Stock ...

EADV 2024 Late Dupilumab Responders Have Unique Molecular Profile In a major potential step toward personalized therapy for atopic dermatitis, data suggest early, late, and no clinical response to ...